Revised Trauma Score Calculator

February 03, 2016

A calculator for assessing cardiologic trauma.

Q-Tc Calculator

February 03, 2016

A calculator that corrects the QT interval for heart rate extremes.

Pressure Gradient Calculator

February 03, 2016

A calculator for determining pressure.

Caffeine and Cardiovascular Risk: Cause for Concern?

By January 26, 2016

Consuming caffeine regularly does not lead to extra heartbeats, according to a new study by researchers at UC San Francisco published in the Journal of the American Heart Association.

Risk of Stroke, MI Up After Shingles Diagnosis

December 17, 2015

Stroke risk appears to more than double in the first week following a shingles diagnosis, with myocardial infarction (MI) risk also climbing, though not by quite as much, according to research published online in PLOS Medicine.

FDA Panel Votes on Vytorin CVD Risk Reduction Indication

By December 15, 2015

A Food and Drug Administration advisory panel has ruled 10 to 5 against allowing Merck claim their drug Vytorin (ezetimibe, simvastatin tablets) reduces the risk of heart attacks and strokes in patients with acute coronary syndromes.

Promising Data for New Combination Antihypertensive

By December 15, 2015

Kitov Pharmaceuticals announced that the Phase 3 study for KIT-302 successfully met its primary efficacy endpoint. KIT-302 was more efficacious at reducing hypertension than amlodipine besylate.

Vagus Nerve Stimulation + Rehab Feasible After Stroke

December 14, 2015

Vagus nerve stimulation (VNS) paired with rehabilitation appears to be feasible and safe for patients after ischemic stroke, according to a study published online in Stroke.

Nitrates in Heart Failure May Harm More Than Help

December 10, 2015

Nitrates don't improve quality of life or everyday activity levels as intended in patients with heart failure, according to research published in the December 10 issue of the New England Journal of Medicine.

Is Acute Pancreatitis More Common in Statin Users?

By December 07, 2015

Small gallstones could be the cause of idiopathic pancreatitis in up to 10-20% of cases, a new study from the University of Eastern Finland has found

Septic Shock Death Equal With High, Low BP Target

March 19, 2014

For patients with septic shock undergoing resuscitation, 28- and 90-day mortality is not significantly different with high- or low-target arterial pressure.

Cardiac Risk From Breast Radiation Lower Than in Past

October 30, 2013

Risk of cardiac events is increased by exposure from breast radiotherapy, though contemporary techniques, including lower radiation doses and prone positioning, have helped lower these risks.

Seniors Need Personalized Secondary Prevention of CVD

October 30, 2013

For older adults, secondary prevention of atherosclerotic cardiovascular disease (ASCVD) should be individualized.

Opsumit Approved for Pulmonary Arterial Hypertension

October 21, 2013

Actelion announced that the FDA has approved Opsumit (macitentan) tablets for the treatment of pulmonary arterial hypertension (PAH) to delay disease progression.

IBD Ups Risk of Certain Arterial Thromboembolic Events

October 16, 2013

The risk of cerebrovascular accident was significantly increased with IBD, particularly in females and young adults.

Hypertension and Substance Abuse Mask an Underlying Condition

October 14, 2013

A middle-aged man presents with 
palpitations, tachycardia, tremors, 
and extreme anxiety.

Esmolol Tied to Reduced Heart Rate in Septic Shock

October 10, 2013

For patients in septic shock, the use of esmolol is linked to reductions in heart rates to target levels compared to the use of standard care.

First-in-Class Drug for Pulmonary Hypertension Approved

October 09, 2013

Bayer HealthCare announced that the FDA has approved Adempas (riociguat) tablets, a first-in-class drug, for the treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension.

Novel Drug For Pulmonary Hypertension Awaits Approval

September 25, 2013

The FDA has granted Orphan Drug Designation to riociguat (Bayer HealthCare), proposed trade name Adempas, for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).

Access to Artificial Heart Valve Expanded for Inoperable Patients

September 24, 2013

The FDA approved labeling revisions for the Sapien Transcatheter Heart Valve (THV), expanding its availability to patients who have inoperable aortic valve stenosis.

Infectious Endocarditis Risk ID'd in Congenital Heart Disease

September 24, 2013

For children with congenital heart disease, the risk of infectious endocarditis is 6.1 per 1,000 children.

Digoxin Use Ups Risk of Death in Systolic Heart Failure

September 23, 2013

Incident digoxin use was linked with higher rates of death and heart failure hospitalization.

Can Super Bowl Heartbreak Lead to Heart Attack?

September 19, 2013

Though many experience excitement, fun, and camaraderie while watching the big event, Super Bowl Sunday has a darker side. It is associated with higher rates of alcohol-related accidents and increased risk of cardiovascular deaths.

FDA Reviews Oral Treprostinil for Pulmonary Arterial Hypertension

September 12, 2013

United Therapeutics announced that the FDA has accepted for review its resubmission of a New Drug Application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension.

ESC: Complications Noted After Dabigatran Heart Valve Tx

September 04, 2013

Patients with heart valve replacements have greater rates of thromboembolic and bleeding complications after treatment with dabigatran vs. warfarin.

ECS: Preventive PCI Cuts Future Cardio Risk in STEMI

September 03, 2013

For patients with acute ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) in non-infarct coronary arteries with major stenoses (preventive PCI) is associated with reduced subsequent cardiovascular risk.

Gene Variant Linked to Heart Disease in Type 2 Diabetes

August 28, 2013

A variant of a gene associated with glutamic acid metabolism is linked to an increased risk of coronary heart disease in patients with type 2 diabetes.

Subcutaneous ICD Is Effective Without Wires Touching Heart

August 27, 2013

The subcutaneous implantable cardioverter-defibrillator (S-ICD System) is both safe and effective for the treatment of life-threatening ventricular arrhythmias.

Physician Continuity Improves Heart Failure Outcomes

August 26, 2013

Both early physician follow-up and continuity of physician care following an initial hospital diagnosis of heart failure improve patient outcomes.